Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors

[1]  Chulmin Park,et al.  Establishment of Experimental Murine Peritonitis Model with Hog Gastric Mucin for Carbapenem-Resistant Gram-Negative Bacteria , 2017, Infection & chemotherapy.

[2]  Robert A Bonomo,et al.  B1-Metallo-β-Lactamases: Where Do We Stand? , 2016, Current drug targets.

[3]  R. Bonomo,et al.  Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes , 2016, Proceedings of the National Academy of Sciences.

[4]  R. Bonomo,et al.  Membrane-anchoring stabilizes and favors secretion of New Delhi Metallo-β-lactamase , 2016, Nature chemical biology.

[5]  I. Henderson,et al.  Alternatives to antibiotics-a pipeline portfolio review. , 2016, The Lancet. Infectious diseases.

[6]  David Brown,et al.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? , 2015, Nature Reviews Drug Discovery.

[7]  Hongzhe Sun,et al.  Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography. , 2015, Chemical communications.

[8]  D. Nicolau,et al.  Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics , 2015, Infection and Drug Resistance.

[9]  S. Reardon.  Antibiotic alternatives rev up bacterial arms race , 2015, Nature.

[10]  Kwok‐yin Wong,et al.  Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1). , 2015, Chemical communications.

[11]  Ewgenij Proschak,et al.  Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria. , 2015, Journal of medicinal chemistry.

[12]  I. Olsen,et al.  New promising β-lactamase inhibitors for clinical use , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[13]  Peter G. Schultz,et al.  Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis , 2015, Proceedings of the National Academy of Sciences.

[14]  Hongzhe Sun,et al.  Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells , 2015, Proceedings of the National Academy of Sciences.

[15]  R. Bonomo,et al.  Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam , 2015, Antimicrobial Agents and Chemotherapy.

[16]  A. Mathers.  Antibiotics in Laboratory Medicine, 6th Edition , 2015 .

[17]  K. Lewis,et al.  A new antibiotic kills pathogens without detectable resistance , 2015, Nature.

[18]  C. Schofield,et al.  Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition. , 2014, Nature chemistry.

[19]  P. Nordlund,et al.  The cellular thermal shift assay for evaluating drug target interactions in cells , 2014, Nature Protocols.

[20]  N. Strynadka,et al.  Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance , 2014, Nature.

[21]  P. Nordmann,et al.  Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria , 2014, BioMed research international.

[22]  W. Fast,et al.  Metallo-β-lactamase: inhibitors and reporter substrates. , 2013, Biochimica et biophysica acta.

[23]  P. Nordlund,et al.  Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay , 2013, Science.

[24]  James J. Collins,et al.  Silver Enhances Antibiotic Activity Against Gram-Negative Bacteria , 2013, Science Translational Medicine.

[25]  Joe J. Harrison,et al.  Antimicrobial activity of metals: mechanisms, molecular targets and applications , 2013, Nature Reviews Microbiology.

[26]  Nicolas P E Barry,et al.  Exploration of the medical periodic table: towards new targets. , 2013, Chemical communications.

[27]  T. Palzkill.  Metallo‐β‐lactamase structure and function , 2013, Annals of the New York Academy of Sciences.

[28]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[29]  P. Visca,et al.  In Vitro and In Vivo Antimicrobial Activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumannii , 2012, Antimicrobial Agents and Chemotherapy.

[30]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[31]  Hongzhe Sun,et al.  Recent advances in bioinorganic chemistry of bismuth , 2012, Current Opinion in Chemical Biology.

[32]  B. Berçot,et al.  Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers. , 2011, Diagnostic microbiology and infectious disease.

[33]  D. Livermore,et al.  The emerging NDM carbapenemases. , 2011, Trends in microbiology.

[34]  Cheng Luo,et al.  Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant , 2011, PloS one.

[35]  Quan Hao,et al.  Crystal structure of NDM‐1 reveals a common β‐lactam hydrolysis mechanism , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  J. Gisbert.  Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy , 2011, Nature Reviews Gastroenterology &Hepatology.

[37]  Mike Tyers,et al.  Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. , 2011, Nature chemical biology.

[38]  G. Cornaglia,et al.  Metallo-β-lactamases: a last frontier for β-lactams? , 2011, The Lancet. Infectious diseases.

[39]  S. Lok,et al.  Complete Sequencing of pNDM-HK Encoding NDM-1 Carbapenemase from a Multidrug-Resistant Escherichia coli Strain Isolated in Hong Kong , 2011, PloS one.

[40]  N. Pannu,et al.  REFMAC5 for the refinement of macromolecular crystal structures , 2011, Acta crystallographica. Section D, Biological crystallography.

[41]  Ronald N. Jones,et al.  Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007 , 2010, Antimicrobial Agents and Chemotherapy.

[42]  Hongzhe Sun.  Biological Chemistry of Arsenic, Antimony and Bismuth , 2010 .

[43]  Hongzhe Sun,et al.  Biological Chemistry of Antimony and Bismuth , 2010 .

[44]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[45]  E. Sauvage,et al.  Current Challenges in Antimicrobial Chemotherapy , 2010, Drugs.

[46]  Hongzhe Sun,et al.  A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin , 2010, Proceedings of the National Academy of Sciences.

[47]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[48]  Vincent B. Chen,et al.  MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[49]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[50]  C. Bebrone.  Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. , 2007, Biochemical pharmacology.

[51]  J. Tanner,et al.  Bismuth Complexes Inhibit the SARS Coronavirus† , 2007, Angewandte Chemie.

[52]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[53]  S. Shapiro,et al.  Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin , 2005, Antimicrobial Agents and Chemotherapy.

[54]  A. Logan.  When the drugs don't work. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[55]  G. Jacoby,et al.  The new beta-lactamases. , 2005, The New England journal of medicine.

[56]  S. Benbadis,et al.  When drugs don’t work , 2000, Neurology.

[57]  J. O'donohue,et al.  Treatment of Helicobacter pylori infection , 2000, BMJ : British Medical Journal.

[58]  G. Tytgat,et al.  A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule , 2000, American Journal of Gastroenterology.

[59]  T. Pinheiro,et al.  Distribution of Bismuth in the Rat after Oral Dosing with Ranitidine Bismuth Citrate and Bismuth Subcitrate , 1998, The Journal of pharmacy and pharmacology.

[60]  P. Benfield,et al.  Colloidal Bismuth Subcitrate , 1988, Drugs.

[61]  L. Reimer,et al.  Antibiotics in laboratory medicine , 1987 .

[62]  J. Weber,et al.  Fluorescence quenching titration for determination of complexing capacities and stability constants of fulvic acid , 1982 .

[63]  J. Hakkesteegt.  [A REACTION FOR THE DETERMINATION OF THE IDENTITY OF BISMUTH-TETRABROMOCATECHOL]. , 1964, Pharmaceutisch weekblad.

[64]  A. J. Lehman,et al.  INTRAMUSCULAR INJECTION OF SOBISMINOL: ABSORPTION AND DISTRIBUTION OF BISMUTH , 1938 .

[65]  J. Klauder.  INTRAVENOUS INJECTIONS OF BISMUTH COMPOUNDS IN THE TREATMENT OF SYPHILIS: ITS USE CLINICALLY AND IN EXPERIMENTAL SYPHILIS IN RABBITS , 1928 .

[66]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[67]  W. Chey,et al.  Clinical Guideline : Treatment of Helicobacter pylori Infection , 2017 .

[68]  S. Reardon.  Bacterial arms race revs up. , 2015, Nature.

[69]  Taiyi Wang,et al.  Simplified captopril analogues as NDM-1 inhibitors. , 2014, Bioorganic & medicinal chemistry letters.

[70]  N Woodford,et al.  Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. , 2011, The Journal of antimicrobial chemotherapy.

[71]  N. Khardori.  NDM-1 — A Cause for Worldwide Concern , 2011 .

[72]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[73]  R. Cantón,et al.  IRT and CMT β‐lactamases and inhibitor resistance , 2008 .

[74]  Leslie D. Pettit,et al.  The IUPAC stability constants database , 2006 .

[75]  V. Lorian.  Antibiotics in laboratory medicine , 2005 .

[76]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[77]  A. Simjee.  Colloidal bismuth subcitrate. , 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.